NewLimit
NewLimit is a biotechnology company developing epigenetic medicines to treat age-related diseases. Founded in 2022 and based in South San Francisco, it has raised $682M in funding and employs 60 people.
The growth story
NewLimit grew from 1 to 60 employees between 2021 and 2026, raising $682M along the way, most recently a Series C in June 2026.
About
NewLimit develops therapies targeting the epigenome to restore regenerative potential in aged and diseased cells. Its approach combines functional genomics, pooled perturbation screening, and machine learning to study epigenetic aging at scale. The company’s therapies aim to treat age-related diseases by reprogramming cellular function.
Since its founding in 2022, NewLimit has rapidly scaled to 60 employees and secured $682M in funding, including a Series C round in 2026. Its research-focused team leverages advanced technologies to explore new therapeutic mechanisms for extending human healthspan.
Founders and leadership
NewLimit’s organization is heavily research-focused, with 25 employees dedicated to research functions. The company’s leadership and team are concentrated in South San Francisco, a hub for biotechnology innovation.
The NewLimit org chart
Jacob Kimmel (Co-founder & CEO) leads 14 mapped leaders with 9 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 33 (+74% YoY), Business Development 6 (+20% YoY), Operations 5 (0% YoY), Engineering 4 (-20% YoY), Human Resources 4 (+100% YoY), Entrepreneurship 3 (+200% YoY).
Talent flow
NewLimit’s team draws heavily from top academic institutions, including the University of California, San Francisco, Stanford University, and the University of California, Berkeley. Alumni have moved to roles at companies like 3T Biosciences and Xaira Therapeutics.
Most common previous employers of NewLimit staff: University of California, San Francisco (6), Stanford University (4), University of California, Berkeley (3), Deloitte (2), Calico Life Sciences (2), IBM (2). Former NewLimit employees most often moved to 3T Biosciences (2), Propel Careers (1), ARK Investment Management (1), EvolutionaryScale (1), Americans for Responsible Innovation (1), Xaira Therapeutics (1).
Alumni worth knowing
Hiring now
Web traffic
Traffic mix: 19% direct, 48% search, 9% social, 0% paid.
What this company is made of
Most common skills at NewLimit: Research Skills (27), Molecular Biology (23), Cell Culture (17), Python (Programming Language) (17), Polymerase Chain Reaction (PCR) (15), Cell Biology (15), R (Programming Language) (15), Data Analysis (14).
Where the team actually sits
NewLimit people are concentrated in California, United States (25), San Francisco Bay Area (12), United States (2), Los Angeles Metropolitan Area (1).
Search footprint
NewLimit attracts about 50 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 12 ranking keywords and lost 10 in the last period.
Frequently asked
NewLimit has 60 employees as of September 2026.
NewLimit has raised $682M in total, most recently a Series C round in June 2026.
NewLimit was founded in 2022 by Jacob Kimmel, Blake Byers, Brian Armstrong.
Jacob Kimmel (Co-founder & CEO) sits at the top of NewLimit's reporting structure, with 9 direct reports.
The most common previous employers of current NewLimit staff are University of California, San Francisco (6 people), Stanford University (4 people), University of California, Berkeley (3 people).
Former NewLimit employees most often move to 3T Biosciences (2), Propel Careers (1), ARK Investment Management (1).
NewLimit attracts about 50 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among NewLimit staff are Research Skills, Molecular Biology, Cell Culture, Python (Programming Language), Polymerase Chain Reaction (PCR).
NewLimit staff are concentrated in California, United States (25), San Francisco Bay Area (12), United States (2).
NewLimit has about 33 people in Research, up 74% over the past year, as of September 2026.
NewLimit has about 6 people in Business Development, up 20% over the past year, as of September 2026.
Computed from 41 current and 19 former NewLimit profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.